BREAKING
Telix Pharmaceuticals Limited (TLX) has released Q4 2025 earnings results.
Revenue totaled $664.2M for the Q4 2025 period.
Shares fell 2.0% in after-hours trading to $6.41.
Full analysis with detailed breakdown coming shortly on AlphaStreet.
Full Analysis Now Available: Read the complete breakdown